止血および組織密閉剤の世界市場分析:製品別(局所的止血剤、アクティブ、機械的、流動性止血剤、接着剤、組織シーラント、合成組織シーラント、天然組織シーラント、接着バリア製品)、セグメント予測...市場調査レポートについてご紹介

【英文タイトル】Hemostasis And Tissue Sealing Agents Market Analysis By Product (Topical Hemostats, Active, Mechanical, Flowable Hemostats, Adhesives, Tissue Sealants, Synthetic Tissue Sealant, Natural Tissue Sealant, Adhesion Barrier Products) And Segment Forecasts To 2022

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. Hemostasis and tissue sealing agents – Industry Summary and Key Buying Criteria, 2012 – 2022
Chapter 3. Hemostasis and tissue sealing agents Industry Outlook
3.1. Hemostasis and tissue sealing agents market segmentation
3.2. Hemostasis and tissue sealing agents market size and growth prospects, 2012-2022
3.3. Hemostasis and tissue sealing agents market dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Key opportunities prioritized
3.5. Industry analysis – Porter’s
3.6. Hemostasis and tissue sealing agents : Company market share, 2014
3.7. Hemostasis and tissue sealing agents market PESTEL analysis, 2014
Chapter 4. Hemostasis and tissue sealing agents Product Outlook
4.1. Hemostasis and tissue sealing agents market share by product, 2014 & 2022
4.2. Topical hemostats market estimates and forecasts, 2012 – 2022 (USD Million)
4.2.1. Active market estimates and forecasts, 2012 – 2022 (USD Million)
4.2.2. Mechanical market estimates and forecasts, 2012 – 2022 (USD Million)
4.2.3. Flowable market estimates and forecasts, 2012 – 2022 (USD Million)
4.3. Adhesive & tissue sealant market estimates and forecasts, 2012 – 2022 (USD Million)
4.3.1. Synthetic tissue sealant market estimates and forecasts, 2012 – 2022 (USD Million)
4.3.2. Natural tissue sealant market estimates and forecasts, 2012 – 2022 (USD Million)
4.3.3. Adhesion barrier products market estimates and forecasts, 2012 – 2022 (USD Million)
Chapter 5. Hemostasis and tissue sealing agents Regional Outlook
5.1. North America
5.1.1. North America market, by product, 2012 – 2022 (USD Million)
5.1.1.1. U.S. market estimates and forecasts
5.1.1.2. Canada market estimates and forecasts
5.2. Europe
5.2.1. Europe market, by product, 2012 – 2022 (USD Million)
5.2.1.1. UK market estimates and forecasts
5.2.1.2. Germany market estimates and forecasts
5.2.1.3. France market estimates and forecasts
5.2.1.4. Italy market estimates and forecasts
5.2.1.5. Spain market estimates and forecasts
5.3. Asia Pacific
5.3.1. Asia Pacific market, by product, 2012 – 2022 (USD Million)
5.3.1.1. Japan market estimates and forecasts
5.3.1.2. China market estimates and forecasts
5.3.1.3. India market estimates and forecasts
5.4. Latin America
5.4.1. Latin America market, by product, 2012 – 2022 (USD Million)
5.4.1.1. Brazil market estimates and forecasts
5.5. MEA
5.5.1. MEA market, by product, 2012 – 2022 (USD Million)
5.5.1.1. South Africa market estimates and forecasts
Chapter 6. Competitive Landscape
6.1. Johnson & Johnson
6.1.1. Company Overview
6.1.2. Financial Performance
6.1.3. Product Benchmarking
6.1.4. Strategic Initiatives
6.2. CryoLife Inc.
6.2.1. Company Overview
6.2.2. Financial Performance
6.2.3. Product Benchmarking
6.2.4. Strategic Initiatives
6.3. Advance Medical Solution (AMS) Group Plc.
6.3.1. Company Overview
6.3.2. Financial Performance
6.3.3. Product Benchmarking
6.3.4. Strategic Initiatives
6.4. Cohera Medical Inc.
6.4.1. Company Overview
6.4.2. Financial Performance
6.4.3. Product Benchmarking
6.4.4. Strategic Initiatives
6.5. Integra Life Sciences Corporation
6.5.1. Company Overview
6.5.2. Financial Performance
6.5.3. Product Benchmarking
6.5.4. Strategic Initiatives
6.6. Pfizer Inc.
6.6.1. Company Overview
6.6.2. Financial Performance
6.6.3. Product Benchmarking
6.6.4. Strategic Initiatives
6.7. C R Bard Inc.
6.7.1. Company Overview
6.7.2. Financial Performance
6.7.3. Product Benchmarking
6.7.4. Strategic Initiatives
6.8. Cohesion Technologies Inc
6.8.1. Company Overview
6.8.2. Financial Performance
6.8.3. Product Benchmarking
6.8.4. Strategic Initiatives
6.9. HyperBranch Medical Technology
6.9.1. Company Overview
6.9.2. Financial Performance
6.9.3. Product Benchmarking
6.9.4. Strategic Initiatives
6.10. Biomet Inc.
6.10.1. Company Overview
6.10.2. Financial Performance
6.10.3. Product Benchmarking
6.10.4. Strategic Initiatives
6.11. Covidien Plc
6.11.1. Company Overview
6.11.2. Financial Performance
6.11.3. Product Benchmarking
6.11.4. Strategic Initiatives
6.12. B Braun Medical Inc.
6.12.1. Company Overview
6.12.2. Financial Performance
6.12.3. Product Benchmarking
6.12.4. Strategic Initiatives
6.13. Smith & Nephew
6.13.1. Company Overview
6.13.2. Financial Performance
6.13.3. Product Benchmarking
6.13.4. Strategic Initiatives


【レポート販売概要】

■ タイトル:止血および組織密閉剤の世界市場分析:製品別(局所的止血剤、アクティブ、機械的、流動性止血剤、接着剤、組織シーラント、合成組織シーラント、天然組織シーラント、接着バリア製品)、セグメント予測
■ 英文:Hemostasis And Tissue Sealing Agents Market Analysis By Product (Topical Hemostats, Active, Mechanical, Flowable Hemostats, Adhesives, Tissue Sealants, Synthetic Tissue Sealant, Natural Tissue Sealant, Adhesion Barrier Products) And Segment Forecasts To 2022
■ 発行日:2015年11月3日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707393
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。